相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Initial first-in-human phase 1 results of PTC596, a novel small molecule that targets cancer stem cells (CSCs) by reducing BMI1 protein levels
G. Shapiro et al.
ANNALS OF ONCOLOGY (2016)
Inhibition of BMI1 induces autophagy-mediated necroptosis
Anindya Dey et al.
AUTOPHAGY (2016)
BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate Cancer
Nitu Bansal et al.
CLINICAL CANCER RESEARCH (2016)
Pharmacological activation of wild-type p53 in the therapy of leukemia
Kensuke Kojima et al.
EXPERIMENTAL HEMATOLOGY (2016)
Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment
Arnold Bolomsky et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Preclinical activity of the novel B-cell-specific Moloney murine leukemia virus integration site 1 inhibitor PTC-209 in acute myeloid leukemia: Implications for leukemia therapy
Yuki Nishida et al.
CANCER SCIENCE (2015)
Single-Cell Mass Cytometry Reveals Intracellular Survival/Proliferative Signaling in FLT3-ITD-Mutated AML Stem/Progenitor Cells
Lina Han et al.
CYTOMETRY PART A (2015)
The BMI1 polycomb protein represses cyclin G2-induced autophagy to support proliferation in chronic myeloid leukemia cells
L. Mourgues et al.
LEUKEMIA (2015)
Acute Myeloid Leukemia
Hartmut Doehner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Bmi1 Promotes Erythroid Development Through Regulating Ribosome Biogenesis
Rui Gao et al.
STEM CELLS (2015)
Anti-aging Effect of Transplanted Amniotic Membrane Mesenchymal Stem Cells in a Premature Aging Model of Bmi-1 Deficiency
Chunfeng Xie et al.
SCIENTIFIC REPORTS (2015)
BMI1 attenuates etoposide-induced G2/M checkpoints via reducing ATM activation
F. Wei et al.
ONCOGENE (2015)
Heterozygous knockout of the Bmi-1 gene causes an early onset of phenotypes associated with brain aging
Minxia Gu et al.
AGE (2014)
BMI1 gene expression in myeloid leukemias and its impact on prognosis
Niveen S. Saudy et al.
BLOOD CELLS MOLECULES AND DISEASES (2014)
Hypoxia-induced Bmi1 promotes renal tubular epithelial cell-mesenchymal transition and renal fibrosis via PI3K/Akt signal
Rui Du et al.
MOLECULAR BIOLOGY OF THE CELL (2014)
Self-renewal as a therapeutic target in human colorectal cancer
Antonija Kreso et al.
NATURE MEDICINE (2014)
Prognostic impact and targeting of CRM1 in acute myeloid leukemia
Kensuke Kojima et al.
BLOOD (2013)
Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia
Alan H. Shih et al.
HAEMATOLOGICA (2013)
Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation
M. Calao et al.
ONCOGENE (2013)
Proteomic Profiling Identifies Distinct Protein Patterns in Acute Myelogenous Leukemia CD34+CD38-Stem-Like Cells
Steven M. Kornblau et al.
PLOS ONE (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Overexpression of Mcl-1 Confers Multidrug Resistance, Whereas Topoisomerase IIβ Downregulation Introduces Mitoxantrone-Specific Drug Resistance in Acute Myeloid Leukemia
David L. Hermanson et al.
MOLECULAR PHARMACOLOGY (2013)
TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome
Frank G. Rueckner et al.
BLOOD (2012)
A novel hierarchical prognostic model of AML solely based on molecular mutations
Vera Grossmann et al.
BLOOD (2012)
Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia
Stefan P. Glaser et al.
GENES & DEVELOPMENT (2012)
Survival for older patients with acute myeloid leukemia: a population-based study
Betul Oran et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Role of BMI1, a Stem Cell Factor, in Cancer Recurrence and Chemoresistance: Preclinical and Clinical Evidences
Hifzur Rahman Siddique et al.
STEM CELLS (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Bmi1 is essential for leukemic reprogramming of myeloid progenitor cells
J. Yuan et al.
LEUKEMIA (2011)
Mcl-1; the molecular regulation of protein function
Luke W. Thomas et al.
FEBS LETTERS (2010)
Identification and Characterization of Bmi-1-responding Element within the Human p16 Promoter
Sha Meng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Selective FLT3 inhibitor FI-700 neutralizes Mcl-1 and enhances p53-mediated apoptosis in AML cells with activating mutations of FLT3 through Mcl-1/Noxa axis
K. Kojima et al.
LEUKEMIA (2010)
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
Gunnar Juliusson et al.
BLOOD (2009)
FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD-specific STAT5 activation
Goichi Yoshimoto et al.
BLOOD (2009)
Repression of BMI1 in normal and leukemic human CD34+ cells impairs self-renewal and induces apoptosis
Aleksandra Rizo et al.
BLOOD (2009)
The Polycomb Group Gene Bmi1 Regulates Antioxidant Defenses in Neurons by Repressing p53 Pro-Oxidant Activity
Wassim Chatoo et al.
JOURNAL OF NEUROSCIENCE (2009)
Bmi1 regulates mitochondrial function and the DNA damage response pathway
Jie Liu et al.
NATURE (2009)
Unique Biology of Mcl-1: Therapeutic Opportunities in Cancer
Gordon Shore et al.
CURRENT MOLECULAR MEDICINE (2008)
Long-term maintenance of human hematopoietic stem/progenitor cells by expression of BMI1
Aleksandra Rizo et al.
BLOOD (2008)
Bmi-1 is essential for the tumorigenicity of neuroblastoma cells
Hongjuan Cui et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1
U Maurer et al.
MOLECULAR CELL (2006)
MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy
K Kojima et al.
BLOOD (2005)
Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML):: evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides
KJ Aichberger et al.
BLOOD (2005)
Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1
A Iwama et al.
IMMUNITY (2004)
Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells
IK Park et al.
NATURE (2003)
Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells
J Lessard et al.
NATURE (2003)
分享论文
